Show notes
During the COVID pandemic, the vaccine approval process went from eight years to a few months. In addition, the FDA has used several expedited approval pathways, starting in the 1990s with HIV treatments and continuing today. On the next two episodes, Tom talks with two leading experts on these various approval pathways, what medications are on the approval fast track, and other considerations regarding expedited approval today. Moderator:Tomas Villanueva, DO, MBA, FACPE, SFHMSenior Principal, Clinical Operations and QualityVizient Guests:Jeni Hayes, PharmD, MSPharm, BCPSSenior Clinical Manager, Pharmacy OutcomesCenter for Pharmacy Practice ExcellenceVizient Steven Lucio, PharmD, BCPSSenior Principal, Pharmacy SolutionsCenter for Pharmacy Practice ExcellenceVizient Show Notes:[[[[ Links | Resources:To contact Modern Practice: [email protected]Steven’s email: [email protected]Jeni’s email: [email protected]FDA’s accelerated approval update page: Click hereVizient Pharmacy Market Highlights – Dec. 2022: PMO322_PharmacyMarketOutlook_Highlights.pdf Subscribe Today!Apple PodcastsAmazon PodcastsAndroidGoogle PodcastsSpotifyStitcherRSS Feed

